These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9872204)

  • 41. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
    Maier JA; Delia D; Thorpe PE; Gasparini G
    Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vascular endothelial growth factor VEGF stimulates angiogenesis in good and bad situations].
    Heits F; Wiedemann GJ; Jelkmann W
    Dtsch Med Wochenschr; 1998 Feb; 123(9):259-65. PubMed ID: 9524537
    [No Abstract]   [Full Text] [Related]  

  • 43. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
    Melnyk O; Zimmerman M; Kim KJ; Shuman M
    J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
    Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
    Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
    Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tumor progression and angiogenesis].
    Maru Y
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1509-19. PubMed ID: 10500543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of vascular endothelial growth factor and E-selectin on angiogenesis in the murine metastatic RCT sarcoma.
    Aoki M; Kanamori M; Yudoh K; Ohmori K; Yasuda T; Kimura T
    Tumour Biol; 2001; 22(4):239-46. PubMed ID: 11399949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenesis in bladder cancer--prognostic marker and target for future therapy.
    Streeter EH; Harris AL
    Surg Oncol; 2002 Jun; 11(1-2):85-100. PubMed ID: 12031871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.
    Yamamoto Y; Toi M; Kondo S; Matsumoto T; Suzuki H; Kitamura M; Tsuruta K; Taniguchi T; Okamoto A; Mori T; Yoshida M; Ikeda T; Tominaga T
    Clin Cancer Res; 1996 May; 2(5):821-6. PubMed ID: 9816236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
    Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
    Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
    Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H
    Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade.
    Huang J; Frischer JS; Serur A; Kadenhe A; Yokoi A; McCrudden KW; New T; O'Toole K; Zabski S; Rudge JS; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7785-90. PubMed ID: 12805568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
    Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
    J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.
    Melnyk O; Shuman MA; Kim KJ
    Cancer Res; 1996 Feb; 56(4):921-4. PubMed ID: 8631034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.